What are the real benefits versus the real risks
The articles are identical except for minor stylistic and spelling differences in keeping with each journal's style
To further test the robustness of the conclusions, we performed a more elaborate analysis, using as control medications, in addition to rosiglitazone, repaglinide, nateglinide, and glipizide, as originally described: piogitazone, all other sulfonylurea compounds, metformin, and all insulin preparations
By using the Website, User agrees to be bound by the terms and conditions set forth in this Agreement
Clinical trial data show headache occurred in 58% of GLP-1 users, though severe migraines are less common
Here are six of the key insights from the conversation